Benjamin Joseph Littler

USPTO Granted Patents = 34 (Patent Applications = 6)

CIPO Patents = 5 (Patent Applications = 2)

EPO Patents = 12 (Patent Applications = 15)

Average Co-Inventor Count = 7.9

ph-index = 15

Forward Citations = 692(Granted Patents)

Location History:

San Diego, CA (US) (2009 - 2018)
Carlsbad, CA (US) (2013 - 2023)

Company Filing History:

31 out of 1,149

Vertex Pharmaceuticals, Inc.

patents

5 out of 40

Biomed Valley Discoveries, Inc.

patents

2 out of 9

Helsinn Therapeutics (u.s.), Inc.

patents

4. 1 out of 66

Helsinn Healthcare Sa

patents

where one patent can have more than one assignee

Years Active: 2009-2025

Loading Chart...

34 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12415798 - Processes for making modulators of cystic fibrosis transmembrane conductance regulator (2025-09-16),

2. 12187698 - Crystalline forms of CHClNO (2025-01-07),

3. 12122788 - Process of making CFTR modulators (2024-10-22),

4. 11773119 - Prodrugs of pyridone amides useful as modulators of sodium channels (2023-10-03),

5. 11584761 - Process of making CFTR modulators (2023-02-21),

6. 11465985 - Processes for making modulators of cystic fibrosis transmembrane conductance regulator (2022-10-11),

7. 11434201 - Processes for preparing pyrrolidine compounds (2022-09-06),

8. 11390600 - Crystalline forms of CHClNO (2022-07-19),

9. 10822331 - Processes for preparing ATR inhibitors (2020-11-03),

10. 10787472 - Prodrugs of pyridone amides useful as modulators of sodium channels (2020-09-29),

11. 10738027 - Crystalline forms of CHClNO (2020-08-11),

12. 10253054 - Prodrugs of pyridone amides useful as modulators of sodium channels (2019-04-09),

13. 10208027 - Processes for preparing ATR inhibitors (2019-02-19),

14. 10183927 - [object Object] (2019-01-22),

15. 10071979 - Process of producing cycloalkylcarboxamido-indole compounds (2018-09-11),

Title: Innovations and Contributions of Benjamin Joseph Littler

Introduction

Benjamin Joseph Littler, based in Carlsbad, California, is an accomplished inventor recognized for his notable contributions in the field of pharmaceuticals. With a remarkable portfolio of 33 patents, Littler's work focuses on innovative compounds that play a crucial role in the treatment of various diseases, including cancer.

Latest Patents

Among his recent innovations, Littler has developed crystalline forms of CHClNO, which are essential for creating effective pharmaceutical compositions. These compositions are designed for the treatment of cancer, demonstrating his commitment to advancing medical science. Additionally, he has disclosed processes for synthesizing CFTR modulators and their pharmaceutically acceptable salts, further contributing to the treatment options available for patients.

Career Highlights

Littler has had an impressive career, having worked with esteemed companies such as Vertex Pharmaceuticals, Inc. and Biomed Valley Discoveries, Inc. His work in these organizations has significantly advanced the development of therapeutic solutions in the pharmaceutical industry.

Collaborations

Throughout his career, Benjamin has collaborated with talented professionals, including Robert Michael Hughes and Ali Keshavarz-Shokri. These partnerships have fostered innovation and enabled the successful development and patenting of critical pharmaceutical inventions.

Conclusion

Benjamin Joseph Littler's dedication to innovation in pharmaceuticals is evident through his extensive patent portfolio and successful collaborations. His contributions continue to impact the treatment landscape, providing hope for patients facing challenging health conditions. His work exemplifies the importance of research and innovation in the quest for effective medical therapies.

This text is generated by artificial intelligence and may not be accurate.